XTL Acquires Stake In iviGene

Ltd has acquired a stake in U.S.-based Corporation. The acquisition gives XTL access to ‘s proprietary IVIAT technology for identifying novel drug targets for treating a broad range of infectious diseases.

The technology is expected to enable XTL to develop both novel human monoclonal antibody and small molecule drugs for antiviral, antibacterial and antifungal infections.

Under the terms of the deal, XTL purchased a 20% minority stake in Florida-based for $1 million and has agreed to fund certain research activities over the next 18 months.

Additionally, XTL has the option to acquire the remaining 80% of for $4 million in cash and $16 million in XTL shares.

In connection with the collaboration, Glenn Kazo, Chief Business Officer and General Manager of XTL’s U.S. subsidiary, will be added to the Board of Directors.

iviGene’s In Vivo Induced Antigen Technology (IVIAT) is a rapid and efficient functional genomics technology that rapidly sifts through a pathogen’s genes to identify in vivo- induced protein expression.

By using in vivo expression rather than in vitro expression, IVIAT avoids problems caused by the expression of non-pathogenic genes.

“We are excited about working with and using its technology to gain access to valuable infectious disease targets,” stated Martin Becker, President and CEO of XTL Biopharmaceuticals.

“This collaboration fits our strategy of continuing to strengthen our infectious disease program and it offers the potential for fueling XTL’s growing pipeline,” added Becker.

Mento Soponis, President and CEO of said, “The wide applicability of IVIAT to human pathogens has already been demonstrated in the lab, and we are pleased that XTL has decided to invest its financial and scientific resources in at this time.

We expect that by combining IVIAT with XTL’s Trimera technology for developing human monoclonal antibodies, we will make rapid progress in advancing compounds into the clinic,” added Soponis.

Dragon Pharmaceuticals Overseas

Cut Mix 150 - Cheap Price

Administration: Injection
Primary Substance: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate
Branded by: Dragon Pharma
Amount: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $46.00

EQ 300 - Bulk Price

Administration: Injection
Base Ingredient: Boldenone Undecylenate
Made by: Dragon Pharma LLC
Amount: 10 x 10 mL vial (300 mg/mL)
Price: 10 x $42.00

Winstrol Tabs - Bulk Price

Administration: Oral
Principal Substance: Stanozolol
Branded by: Dragon Pharma LLC
Amount: 10 x 100 pastilles (50 mg/pastille)
Price: 10 x $63.00

Clomid - Cheap Price

Administration: Oral
Main Ingredient: Clomiphene Citrate
Produced by: Dragon Pharma Labs
Package: 20 x 100 tablets (50 mg/pastille)
Price: 20 x $58.00

Deca 300 - Cheap Price

Administration: Injection
Basal Substance: Nandrolone Decanoate
Produced by: Dragon Pharma Labs
Unit: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $37.00

Trenbolone 200 - Bulk Price

Administration: Injection
Basal Chemical Name: Trenbolone Enanthate
Producer: Dragon Pharma LLC
Unit: 10 x 10 mL vial (200 mg/mL)
Price: 10 x $77.00

Suspension 100

Injectable Anabolic Steroid
Principal Ingredient: Testosterone Suspension
Branded by: Dragon Pharmaceutical
Amount: 1 X 10 ml (100 mg/ml)

Parabolan 100 - Cheap Price

Administration: Injection
Base Constituent: Trenbolone Hexahydrobenzylcarbonate
Manufacturer: Dragon Pharma
Unit: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $55.00

Enantat 400

Injectable Anabolic Steroid
Active Ingredient: Testosterone Enanthate
Manufacturer: Dragon Pharmaceuticals
Unit: 1 X 10 ml (400 mg/ml)

Tritren 150 [10 Vials]

Injectable Steroid for Muscle Growth
Mix of:
- 50mg of Trenbolone Acetate
- 50mg of Trenbolone Enanthate
- 50mg of Trenbolone Hexahydrobenzylcarbonate
Branded by: Dragon Pharmaceutical
10 Vials [10 mL per Vial (150 mg/ml)]
Price: 10 x $72.00 = $720.00 in Total

1-Test Cyp 200

Injectable Steroid for Muscle Growth
Main Component: Dihydroboldenone Cypionate
Branded by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (200 mg/mL)

Nolvadex

Active Chemical Name: Tamoxifen Citrate
Producer: Dragon Pharma
Amount: 100 tablets (50 mg/tablet)